137 related articles for article (PubMed ID: 37364502)
61. The ERM proteins ezrin and moesin regulate retrograde Shiga toxin transport.
Kvalvaag AS; Pust S; Sundet KI; Engedal N; Simm R; Sandvig K
Traffic; 2013 Jul; 14(7):839-52. PubMed ID: 23593995
[TBL] [Abstract][Full Text] [Related]
62. RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation.
Zhang L; Yu J; Zheng M; Zhen H; Xie Q; Zhang C; Zhou Z; Jin G
Commun Biol; 2023 Feb; 6(1):211. PubMed ID: 36823443
[TBL] [Abstract][Full Text] [Related]
63. The ERM-1 membrane-binding domain directs erm-1 mRNA localization to the plasma membrane in the C. elegans embryo.
Winkenbach LP; Parker DM; Williams RTP; Nishimura EO
Development; 2022 Nov; 149(22):. PubMed ID: 36314842
[TBL] [Abstract][Full Text] [Related]
64. Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain.
Shcherbina A; Bretscher A; Kenney DM; Remold-O'Donnell E
FEBS Lett; 1999 Jan; 443(1):31-6. PubMed ID: 9928947
[TBL] [Abstract][Full Text] [Related]
65. TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
Petrova PS; Viller NN; Wong M; Pang X; Lin GH; Dodge K; Chai V; Chen H; Lee V; House V; Vigo NT; Jin D; Mutukura T; Charbonneau M; Truong T; Viau S; Johnson LD; Linderoth E; Sievers EL; Maleki Vareki S; Figueredo R; Pampillo M; Koropatnick J; Trudel S; Mbong N; Jin L; Wang JC; Uger RA
Clin Cancer Res; 2017 Feb; 23(4):1068-1079. PubMed ID: 27856600
[No Abstract] [Full Text] [Related]
66. CD47/SIRPα pathway mediates cancer immune escape and immunotherapy.
Jia X; Yan B; Tian X; Liu Q; Jin J; Shi J; Hou Y
Int J Biol Sci; 2021; 17(13):3281-3287. PubMed ID: 34512146
[TBL] [Abstract][Full Text] [Related]
67. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Willingham SB; Volkmer JP; Gentles AJ; Sahoo D; Dalerba P; Mitra SS; Wang J; Contreras-Trujillo H; Martin R; Cohen JD; Lovelace P; Scheeren FA; Chao MP; Weiskopf K; Tang C; Volkmer AK; Naik TJ; Storm TA; Mosley AR; Edris B; Schmid SM; Sun CK; Chua MS; Murillo O; Rajendran P; Cha AC; Chin RK; Kim D; Adorno M; Raveh T; Tseng D; Jaiswal S; Enger PØ; Steinberg GK; Li G; So SK; Majeti R; Harsh GR; van de Rijn M; Teng NN; Sunwoo JB; Alizadeh AA; Clarke MF; Weissman IL
Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6662-7. PubMed ID: 22451913
[TBL] [Abstract][Full Text] [Related]
68. Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation.
Orr Gandy KA; Adada M; Canals D; Carroll B; Roddy P; Hannun YA; Obeid LM
FASEB J; 2013 Aug; 27(8):3155-66. PubMed ID: 23629860
[TBL] [Abstract][Full Text] [Related]
69. CD47: the next checkpoint target for cancer immunotherapy.
Feng R; Zhao H; Xu J; Shen C
Crit Rev Oncol Hematol; 2020 Aug; 152():103014. PubMed ID: 32535479
[TBL] [Abstract][Full Text] [Related]
70. Immunolocalization of CD44 and the ezrin-radixin-moesin (ERM) family in the stratum intermedium and papillary layer of the mouse enamel organ.
Nakamura H; Ozawa H
J Histochem Cytochem; 1997 Nov; 45(11):1481-92. PubMed ID: 9358850
[TBL] [Abstract][Full Text] [Related]
71. A biophysical perspective of the regulatory mechanisms of ezrin/radixin/moesin proteins.
Senju Y; Tsai FC
Biophys Rev; 2022 Feb; 14(1):199-208. PubMed ID: 35340609
[TBL] [Abstract][Full Text] [Related]
72. Foxj1 is required for apical localization of ezrin in airway epithelial cells.
Huang T; You Y; Spoor MS; Richer EJ; Kudva VV; Paige RC; Seiler MP; Liebler JM; Zabner J; Plopper CG; Brody SL
J Cell Sci; 2003 Dec; 116(Pt 24):4935-45. PubMed ID: 14625387
[TBL] [Abstract][Full Text] [Related]
73. Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint.
Wu ZH; Li N; Mei XF; Chen J; Wang XZ; Guo TT; Chen G; Nie L; Chen Y; Jiang MZ; Wang JT; Wang HB
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35256517
[TBL] [Abstract][Full Text] [Related]
74. Activation of moesin, a protein that links actin cytoskeleton to the plasma membrane, occurs by phosphatidylinositol 4,5-bisphosphate (PIP2) binding sequentially to two sites and releasing an autoinhibitory linker.
Ben-Aissa K; Patino-Lopez G; Belkina NV; Maniti O; Rosales T; Hao JJ; Kruhlak MJ; Knutson JR; Picart C; Shaw S
J Biol Chem; 2012 May; 287(20):16311-23. PubMed ID: 22433855
[TBL] [Abstract][Full Text] [Related]
75. Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.
Kawase A; Inoue Y; Nakazaki S; Koizumi E; Iwaki M
Oncol Rep; 2019 Jul; 42(1):283-290. PubMed ID: 31115547
[TBL] [Abstract][Full Text] [Related]
76. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells.
Kamioka H; Edaki K; Kasahara H; Tomono T; Yano K; Ogihara T
J Pharm Pharmacol; 2021 Dec; 73(12):1609-1616. PubMed ID: 34313784
[TBL] [Abstract][Full Text] [Related]
77. Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection.
Bukong TN; Kodys K; Szabo G
Hepatology; 2013 Nov; 58(5):1569-79. PubMed ID: 23703860
[TBL] [Abstract][Full Text] [Related]
78. Analysis of a cortical cytoskeletal structure: a role for ezrin-radixin-moesin (ERM proteins) in the marginal band of chicken erythrocytes.
Winckler B; González Agosti C; Magendantz M; Solomon F
J Cell Sci; 1994 Sep; 107 ( Pt 9)():2523-34. PubMed ID: 7531201
[TBL] [Abstract][Full Text] [Related]
79. CD47-signal regulatory protein α signaling system and its application to cancer immunotherapy.
Murata Y; Saito Y; Kotani T; Matozaki T
Cancer Sci; 2018 Aug; 109(8):2349-2357. PubMed ID: 29873856
[TBL] [Abstract][Full Text] [Related]
80. Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes.
Wang W; Soroka CJ; Mennone A; Rahner C; Harry K; Pypaert M; Boyer JL
Gastroenterology; 2006 Sep; 131(3):878-84. PubMed ID: 16952556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
